Vaccines and Preventable Diseases

  • Tetanus (Lockjaw)

    Brief Description

    Tetanus (lockjaw) is a serious disease that causes painful tightening of the muscles, usually all over the body. It can lead to "locking" of the jaw so the victim cannot open his mouth or swallow. Tetanus leads to death in about 1 in 10 cases. Several vaccines are used to prevent tetanus among children, adolescents, and adults including DTaP, Tdap, DT, and Td.

    Vaccine Information

    Diphtheria, Tetanus, and Pertussis Vaccines

    There are four combination vaccines used to prevent diphtheria, tetanus and pertussis: DTaP, Tdap, DT, and Td. Two of these (DTaP and DT) are given to children younger than 7 years of age, and two (Tdap and Td) are given to older children and adults. Several other combination vaccines contain DTaP along with other childhood vaccines.

    Children should get 5 doses of DTaP, one dose at each of the following ages: 2, 4, 6, and 15-18 months and 4-6 years. DT does not contain pertussis, and is used as a substitute for DTaP for children who cannot tolerate pertussis vaccine.

    Td is a tetanus-diphtheria vaccine given to adolescents and adults as a booster shot every 10 years, or after an exposure to tetanus under some circumstances. Tdap is similar to Td but also containing protection against pertussis. Adolescents 11-18 years of age (preferably at age 11-12 years) and adults 19 through 64 years of age should receive a single dose of Tdap. For adults 65 and older who have close contact with an infant and have not previously received Tdap, one dose should be received. Tdap should also be given to 7-10 year olds who are not fully immunized against pertussis. Tdap can be given no matter when Td was last received.

    [Upper-case letters in these abbreviations denote full-strength doses of diphtheria (D) and tetanus (T) toxoids and pertussis (P) vaccine. Lower-case “d” and “p” denote reduced doses of diphtheria and pertussis used in the adolescent/adult-formulations. The “a” in DTaP and Tdap stands for “acellular,” meaning that the pertussis component contains only a part of the pertussis organism.]

     

  • Chairpersons:            

    Dr. T. U. Sukumaran                
    Dr. Rohit C. Agrawal

    Convener:                  

    Dr. Vipin M. Vashishtha

    Members:

    Dr. Amarjeet Chitkara
    Dr. Manjori Mitra
    Dr. S. Sanjay 
    Dr. S. G. Kasi
    Dr. Suhas V. Prabhu  

    Advisors:

    Dr. Nitin K. Shah
    Dr. Raju C. Shah
    Dr. Naveen Thacker
    Dr. A. Parthasarathy

    Ex-officio:
    Dr.  Panna Choudhury (Chairman, IAPCOI, 2009-11)
    Dr. Vijay N. Yewale (Convener, IAPCOI, 2009-11)